Phase I safety study of lenalidomide and dacarbazine in patients with metastatic melanoma previously untreated with systemic chemotherapy-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Phase I safety study of lenalidomide and dacarbazine in patients with metastatic melanoma previously untreated with systemic chemotherapy

Published:2010-12 Issue:6 Volume:20 Page:501-506
ISSN:0960-8931
Container-title:Melanoma Research
language:en
Short-container-title:

Author:

Hwu Wen-Jen,Knight Robert D.,Patnana Madhavi,Bassett Roland,Papadopoulos Nicholas E.,Kim Kevin B.,Hwu Patrick,Bedikian Agop

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Cancer Research,Dermatology,Oncology

Reference21 articles.

1. Cancer statistics, 2009;Jemal;CA Cancer J Clin,2009

2. Final version of 2009 American Joint Committee on Cancer (AJCC) melanoma staging and classification;Balch;J Clin Oncol,2009

3. Medical progress: management of cutaneous melanoma;Tsao;N Engl J Med,2004

4. Prospective randomized trial of the treatment of patients with metastatic melanoma using chemotherapy with cisplatin, dacarbazine, and tamoxifen alone or in combination with interleukin-2 and interferon alfa-2b;Rosenberg;J Clin Oncol,1999

5. Phase III trial comparing concurrent biochemotherapy with cisplatin, vinblastine, dacarbazine, interleukin-2, and interferon alfa-2b with cisplatin, vinblastine, and dacarbazine alone in patients with metastatic malignant melanoma (E3695): a trial coordinated by the Eastern Cooperative Oncology Group;Atkins;J Clin Oncol,2008

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. VEGF/VEGFR axis and its signaling in melanoma: Current knowledge toward therapeutic targeting agents and future perspectives;Life Sciences;2024-05

2. Lenalidomide arrests cell cycle and modulates PD1-dependent downstream mTOR intracellular signals in melanoma cells;Melanoma Research;2023-07-12

3. Hypoxia-dependent drivers of melanoma progression;Journal of Experimental & Clinical Cancer Research;2021-05-08

4. A computational method for drug sensitivity prediction of cancer cell lines based on various molecular information;PLOS ONE;2021-04-29

5. Lenalidomide Enhances CAR-T Cell Activity Against Solid Tumor Cells;Cell Transplantation;2020-01-01

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3